Sfoglia per Autore
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis
2017 Eusebi, Paolo; Hansson, Oskar; Paciotti, Silvia; Orso, Massimiliano; Chiasserini, Davide; Calabresi, Paolo; Blennow, Kaj; Parnetti, Lucilla
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinsonâs disease
2017 Farotti, Lucia; Paciotti, Silvia; Tasegian, Anna; Eusebi, Paolo; Parnetti, Lucilla
Lysosomal enzymes in Parkinson's disease
2017 Beccari, Tommaso; Paciotti, Silvia; Tasegian, Anna; Codini, Michela; Ceccarini, Maria Rachele; Albi, Elisabetta; Cataldi, Samuela; Traina, Giovanna; Conte, Carmela; Parnetti, Lucilla; Bertelli, Matteo
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients
2017 Parnetti, Lucilla; Paciotti, Silvia; Eusebi, Paolo; Dardis, Andrea; Zampieri, Stefania; Chiasserini, Davide; Tasegian, Anna; Tambasco, Nicola; Bembi, Bruno; Calabresi, Paolo; Beccari, Tommaso
Origin of α-mannosidase activity in CSF
2017 Tasegian, Anna; Paciotti, Silvia; Ceccarini, MARIA RACHELE; Codini, Michela; Moors, Tim; Chiasserini, Davide; Albi, Elisabetta; Winchester, Bryan; van de Berg, Wilma D. J.; Parnetti, Lucilla; Beccari, Tommaso
Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer's disease
2018 Lewczuk, Piotr; Gaignaux, Amelie; Kofanova, Olga; Ermann, Natalia; Betsou, Fay; Brandner, Sebastian; Mroczko, Barbara; Blennow, Kaj; Strapagiel, Dominik; Paciotti, Silvia; Vogelgsang, Jonathan; Roehrl Michael, H.; Mendoza, Sandra; Kornhuber, Johannes; Teunissen, Charlotte
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
2018 del Campo, Marta; Galimberti, Daniela; Elias, Naura; Boonkamp, Lynn; Pijnenburg, Yolande A.; van Swieten, John C.; Watts, Kelly; Paciotti, Silvia; Beccari, Tommaso; Hu, William; Teunissen, Charlotte E.
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools
2018 Paciotti, Silvia; Bellomo, Giovanni; Gatticchi, Leonardo; Parnetti, Lucilla
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
2018 Moors, Tim E.; Paciotti, Silvia; Ingrassia, Angela; Quadri, Marialuisa; Breedveld, Guido; Tasegian, Anna; Chiasserini, Davide; Eusebi, Paolo; Duran-Pacheco, Gonzalo; Kremer, Thomas; Calabresi, Paolo; Bonifati, Vincenzo; Parnetti, Lucilla; Beccari, Tommaso; van de Berg, Wilma D. J.
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids
2019 Bellomo, G.; Bologna, S.; Cerofolini, L.; Paciotti, S.; Gatticchi, L.; Ravera, E.; Parnetti, L.; Fragai, M.; Luchinat, C.
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction
2019 Bellomo, G.; Paciotti, S.; Gatticchi, L.; Parnetti, L.
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease
2019 Biscetti, L.; Salvadori, N.; Farotti, L.; Cataldi, S.; Eusebi, P.; Paciotti, S.; Parnetti, L.
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
2019 Paciotti, S.; Gatticchi, L.; Beccari, T.; Parnetti, L.
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
2019 Durante, V.; De Iure, A.; Loffredo, V.; Vaikath, N.; De Risi, M.; Paciotti, S.; Quiroga-Varela, A.; Chiasserini, D.; Mellone, M.; Mazzocchetti, P.; Calabrese, V.; Campanelli, F.; Mechelli, A.; Di Filippo, M.; Ghiglieri, V.; Picconi, B.; El-Agnaf, O. M.; De Leonibus, E.; Gardoni, F.; Tozzi, A.; Calabresi, P.
CSF and blood biomarkers for Parkinson's disease
2019 Parnetti, L.; Gaetani, L.; Eusebi, P.; Paciotti, S.; Hansson, O.; El-Agnaf, O.; Mollenhauer, B.; Blennow, K.; Calabresi, P.
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis
2019 Paciotti, S.; Sepe, F. N.; Eusebi, P.; Farotti, L.; Cataldi, S.; Gatticchi, L.; Parnetti, L.
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
2019 Sjodin, S.; Brinkmalm, G.; Ohrfelt, A.; Parnetti, L.; Paciotti, S.; Hansson, O.; Hardy, J.; Blennow, K.; Zetterberg, H.; Brinkmalm, A.
Parkinson's and Lewy body dementia CSF biomarkers
2019 Parnetti, L.; Paciotti, S.; Farotti, L.; Bellomo, G.; Sepe, F. N.; Eusebi, P.
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients
2019 Nuzzo, T.; Punzo, D.; Devoto, P.; Rosini, E.; Paciotti, S.; Sacchi, S.; Li, Q.; Thiolat, M. -L.; Vega, C.; Carella, M.; Carta, M.; Gardoni, F.; Calabresi, P.; Pollegioni, L.; Bezard, E.; Parnetti, L.; Errico, F.; Usiello, A.
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ?
2020 Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis | 2017 | Eusebi, Paolo; Hansson, Oskar; Paciotti, Silvia; Orso, Massimiliano; Chiasserini, Davide; Calabresi, Paolo; Blennow, Kaj; Parnetti, Lucilla | |
| Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinsonâs disease | 2017 | Farotti, Lucia; Paciotti, Silvia; Tasegian, Anna; Eusebi, Paolo; Parnetti, Lucilla | |
| Lysosomal enzymes in Parkinson's disease | 2017 | Beccari, Tommaso; Paciotti, Silvia; Tasegian, Anna; Codini, Michela; Ceccarini, Maria Rachele; Albi, Elisabetta; Cataldi, Samuela; Traina, Giovanna; Conte, Carmela; Parnetti, Lucilla; Bertelli, Matteo | |
| Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients | 2017 | Parnetti, Lucilla; Paciotti, Silvia; Eusebi, Paolo; Dardis, Andrea; Zampieri, Stefania; Chiasserini, Davide; Tasegian, Anna; Tambasco, Nicola; Bembi, Bruno; Calabresi, Paolo; Beccari, Tommaso | |
| Origin of α-mannosidase activity in CSF | 2017 | Tasegian, Anna; Paciotti, Silvia; Ceccarini, MARIA RACHELE; Codini, Michela; Moors, Tim; Chiasserini, Davide; Albi, Elisabetta; Winchester, Bryan; van de Berg, Wilma D. J.; Parnetti, Lucilla; Beccari, Tommaso | |
| Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer's disease | 2018 | Lewczuk, Piotr; Gaignaux, Amelie; Kofanova, Olga; Ermann, Natalia; Betsou, Fay; Brandner, Sebastian; Mroczko, Barbara; Blennow, Kaj; Strapagiel, Dominik; Paciotti, Silvia; Vogelgsang, Jonathan; Roehrl Michael, H.; Mendoza, Sandra; Kornhuber, Johannes; Teunissen, Charlotte | |
| Novel CSF biomarkers to discriminate FTLD and its pathological subtypes | 2018 | del Campo, Marta; Galimberti, Daniela; Elias, Naura; Boonkamp, Lynn; Pijnenburg, Yolande A.; van Swieten, John C.; Watts, Kelly; Paciotti, Silvia; Beccari, Tommaso; Hu, William; Teunissen, Charlotte E. | |
| Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools | 2018 | Paciotti, Silvia; Bellomo, Giovanni; Gatticchi, Leonardo; Parnetti, Lucilla | |
| Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies | 2018 | Moors, Tim E.; Paciotti, Silvia; Ingrassia, Angela; Quadri, Marialuisa; Breedveld, Guido; Tasegian, Anna; Chiasserini, Davide; Eusebi, Paolo; Duran-Pacheco, Gonzalo; Kremer, Thomas; Calabresi, Paolo; Bonifati, Vincenzo; Parnetti, Lucilla; Beccari, Tommaso; van de Berg, Wilma D. J. | |
| Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids | 2019 | Bellomo, G.; Bologna, S.; Cerofolini, L.; Paciotti, S.; Gatticchi, L.; Ravera, E.; Parnetti, L.; Fragai, M.; Luchinat, C. | |
| The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction | 2019 | Bellomo, G.; Paciotti, S.; Gatticchi, L.; Parnetti, L. | |
| The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease | 2019 | Biscetti, L.; Salvadori, N.; Farotti, L.; Cataldi, S.; Eusebi, P.; Paciotti, S.; Parnetti, L. | |
| Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies | 2019 | Paciotti, S.; Gatticchi, L.; Beccari, T.; Parnetti, L. | |
| Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration | 2019 | Durante, V.; De Iure, A.; Loffredo, V.; Vaikath, N.; De Risi, M.; Paciotti, S.; Quiroga-Varela, A.; Chiasserini, D.; Mellone, M.; Mazzocchetti, P.; Calabrese, V.; Campanelli, F.; Mechelli, A.; Di Filippo, M.; Ghiglieri, V.; Picconi, B.; El-Agnaf, O. M.; De Leonibus, E.; Gardoni, F.; Tozzi, A.; Calabresi, P. | |
| CSF and blood biomarkers for Parkinson's disease | 2019 | Parnetti, L.; Gaetani, L.; Eusebi, P.; Paciotti, S.; Hansson, O.; El-Agnaf, O.; Mollenhauer, B.; Blennow, K.; Calabresi, P. | |
| Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis | 2019 | Paciotti, S.; Sepe, F. N.; Eusebi, P.; Farotti, L.; Cataldi, S.; Gatticchi, L.; Parnetti, L. | |
| Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease | 2019 | Sjodin, S.; Brinkmalm, G.; Ohrfelt, A.; Parnetti, L.; Paciotti, S.; Hansson, O.; Hardy, J.; Blennow, K.; Zetterberg, H.; Brinkmalm, A. | |
| Parkinson's and Lewy body dementia CSF biomarkers | 2019 | Parnetti, L.; Paciotti, S.; Farotti, L.; Bellomo, G.; Sepe, F. N.; Eusebi, P. | |
| The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients | 2019 | Nuzzo, T.; Punzo, D.; Devoto, P.; Rosini, E.; Paciotti, S.; Sacchi, S.; Li, Q.; Thiolat, M. -L.; Vega, C.; Carella, M.; Carta, M.; Gardoni, F.; Calabresi, P.; Pollegioni, L.; Bezard, E.; Parnetti, L.; Errico, F.; Usiello, A. | |
| Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? | 2020 | Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile